Don Ingber
@doningber
Founding Director @wyssinstitute, Judah Folkman Prof. of Vascular Biology @bostonchildrens & @harvardmed, Hansjörg Wyss Prof. of Bioinspired Engineering @hseas
ID: 1134489701014880256
https://wyss.harvard.edu/team/executive-team/donald-ingber/ 31-05-2019 15:59:57
1,1K Tweet
7,7K Followers
230 Following
Check out this work from the Wesley Wong Lab showing a new methods they've been developing for single-molecule #proteomics that uses nanoscale devices called DNA Nanoswitch Calipers to enable them to reconstruct the 3D geometry of natively folded single-molecule complexes.
Congratulations Natalie Artzi for the election as a fellow of Controlled Release Society #CRS2023 Wyss Institute
We're thrilled to welcome Eli Lilly and Company as a sponsor of the #BrainTargetingProgram. They're joined by others including Alnylam Pharmaceuticals, Visterra Inc, & our sponsor & co-development partner LundbeckUS. Cell Signaling Technologies, Inc & FairJourney Biologics are also partners.
Human organs-on-chips for disease modelling, drug development and personalized medicine go.nature.com/3Lfq997 #Review by Don Ingber Wyss Institute Free to read here: rdcu.be/cJOud #SharedIt
Founding Director Don Ingber shares his personal path from his discovery of how living cells are constructed using “tensegrity” architecture and how this contributed to the birth of the field of Mechanobiology to his more recent work on human Organ Chips. wyss.harvard.edu/media-post/bri…
@emmacproctor Don Ingber If you'd like to know about our current job opportunities, visit wyss.harvard.edu/careers/
Check out this neat project by our grantee Wyss Institute 🫧
Good new drugs are rare, so bad disease models are false positive machines. Nature Reviews Drug Discovery Consilium Scientific John A Hickman
Cheering on our fruitful collaboration with the Walt Lab! This work demonstrates how microneedles coupled with Simoa technology can be used to rapidly assess melanoma treatment responses, even for rare biomarkers! Wyss Institute Don Ingber Rushdy Ahmad, PhD Natalie Artzi
Organ-on-a-Chip Technology Improves Preclinical Toxicology Emulate, Inc. says its human Liver-Chip outperforms animal models, offering higher specificity and sensitivity in assessments of hepatotoxicity. Learn more: ow.ly/R5Eg50PFU6K
Core Faculty member george church at #STATFuture today at 1:55PM. This event is bringing the pioneers who are leading the way to a new era of medicine together (virtually). statnews.com/2023/summit/fu…
I'm proud of the work we're doing in Sustainable Materials at the Wyss Institute & was excited to be part of a fireside chat on this topic yesterday with Angelika Fretzen, Pam Silver, Sophie Bakalar from Collab Fund, and Noel Kinder, former Nike CSO, led by Emily Stoler.